162 related articles for article (PubMed ID: 35504836)
21. Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT.
Constable L; Abrams P; Cooper D; Kilonzo M; Cotterill N; Harding C; Drake MJ; Pardoe MN; McDonald A; Smith R; Norrie J; McCormack K; Ramsay C; Uren A; Mundy T; Glazener C; MacLennan G
Health Technol Assess; 2022 Aug; 26(36):1-152. PubMed ID: 35972773
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
[TBL] [Abstract][Full Text] [Related]
23. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.
Lee WR; Hall MC; McQuellon RP; Case LD; McCullough DL
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):614-23. PubMed ID: 11597800
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG
Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727
[TBL] [Abstract][Full Text] [Related]
25. Mediterranean diet after prostate cancer diagnosis and urinary and sexual functioning: The health professionals follow-up study.
Bauer SR; Van Blarigan EL; Stampfer MJ; Chan JM; Kenfield SA
Prostate; 2018 Feb; 78(3):202-212. PubMed ID: 29194691
[TBL] [Abstract][Full Text] [Related]
26. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
27. Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force.
Villa S; Kendel F; Venderbos L; Rancati T; Bangma C; Carroll P; Denis L; Klotz L; Korfage IJ; Lane AJ; Magnani T; Mastris K; Rannikko A; Roobol M; Trock B; Van den Bergh R; Van Poppel H; Valdagni R; Bellardita L
Eur Urol; 2017 Feb; 71(2):274-280. PubMed ID: 27720532
[TBL] [Abstract][Full Text] [Related]
28. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance.
Parker PA; Davis JW; Latini DM; Baum G; Wang X; Ward JF; Kuban D; Frank SJ; Lee AK; Logothetis CJ; Kim J
BJU Int; 2016 Mar; 117(3):469-77. PubMed ID: 25714186
[TBL] [Abstract][Full Text] [Related]
29. Prospective Long-term Health-related Quality of Life Outcomes After Surgery, Radiotherapy, or Active Surveillance for Localized Prostate Cancer.
Kord E; Jung N; Posielski N; Jiang J; Elsamanoudi S; Chesnut GT; Speir R; Stroup S; Musser J; Ernest A; Tausch T; Flores JP; Porter C
Eur Urol Open Sci; 2023 Feb; 48():60-69. PubMed ID: 36743401
[TBL] [Abstract][Full Text] [Related]
30. The Effects of Focal Therapy for Prostate Cancer on Sexual Function: A Combined Analysis of Three Prospective Trials.
Yap T; Ahmed HU; Hindley RG; Guillaumier S; McCartan N; Dickinson L; Emberton M; Minhas S
Eur Urol; 2016 May; 69(5):844-51. PubMed ID: 26525837
[TBL] [Abstract][Full Text] [Related]
31. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.
Venderbos LD; van den Bergh RC; Roobol MJ; Schröder FH; Essink-Bot ML; Bangma CH; Steyerberg EW; Korfage IJ
Psychooncology; 2015 Mar; 24(3):348-54. PubMed ID: 25138075
[TBL] [Abstract][Full Text] [Related]
32. Effects of Exercise on Cardiorespiratory Fitness and Biochemical Progression in Men With Localized Prostate Cancer Under Active Surveillance: The ERASE Randomized Clinical Trial.
Kang DW; Fairey AS; Boulé NG; Field CJ; Wharton SA; Courneya KS
JAMA Oncol; 2021 Oct; 7(10):1487-1495. PubMed ID: 34410322
[TBL] [Abstract][Full Text] [Related]
33. A Randomized Trial of the Effects of Exercise on Anxiety, Fear of Cancer Progression and Quality of Life in Prostate Cancer Patients on Active Surveillance.
Kang DW; Fairey AS; Boulé NG; Field CJ; Wharton SA; Courneya KS
J Urol; 2022 Apr; 207(4):814-822. PubMed ID: 35179044
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life for men with prostate cancer--an evaluation of outcomes 12-24 months after treatment.
Brassell SA; Elsamanoudi SI; Cullen J; Williams ME; McLeod DG
Urol Oncol; 2013 Nov; 31(8):1504-10. PubMed ID: 22608541
[TBL] [Abstract][Full Text] [Related]
35. How does active surveillance for prostate cancer affect quality of life? A systematic review.
Bellardita L; Valdagni R; van den Bergh R; Randsdorp H; Repetto C; Venderbos LD; Lane JA; Korfage IJ
Eur Urol; 2015 Apr; 67(4):637-45. PubMed ID: 25454617
[TBL] [Abstract][Full Text] [Related]
36. Quality of life in men undergoing active surveillance for localized prostate cancer.
Bergman J; Litwin MS
J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):242-9. PubMed ID: 23271780
[TBL] [Abstract][Full Text] [Related]
37. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.
Bill-Axelson A; Garmo H; Holmberg L; Johansson JE; Adami HO; Steineck G; Johansson E; Rider JR
Eur Urol; 2013 Dec; 64(6):920-8. PubMed ID: 23465517
[TBL] [Abstract][Full Text] [Related]
38. Patient activation and patient-reported outcomes of men from a community pharmacy lifestyle intervention after prostate cancer treatment.
Lemanska A; Poole K; Manders R; Marshall J; Nazar Z; Noble K; Saxton JM; Turner L; Warner G; Griffin BA; Faithfull S
Support Care Cancer; 2022 Jan; 30(1):347-358. PubMed ID: 34286350
[TBL] [Abstract][Full Text] [Related]
39. Quality-of-life outcomes in men treated for localized prostate cancer.
Litwin MS; Hays RD; Fink A; Ganz PA; Leake B; Leach GE; Brook RH
JAMA; 1995 Jan; 273(2):129-35. PubMed ID: 7799493
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.
Vasarainen H; Lokman U; Ruutu M; Taari K; Rannikko A
BJU Int; 2012 Jun; 109(11):1614-9. PubMed ID: 22044485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
